Mark T Frost bought HBIO once, on Mar 16, 2026

Mark T. Frost is the Chief Financial Officer (CFO) and Treasurer of Harvard Bioscience, Inc. (HBIO), a Holliston, Massachusetts-based biotechnology company specializing in technologies for life science research, drug discovery, and preclinical testing.( He was appointed permanent CFO following his role as interim CFO since spring 2025, after serving as a consultant to the company from January 2025, succeeding Jennifer Cote.(

Frost brings over 30 years of financial and executive management experience across public and private companies. His career highlights include CFO roles at Fathom Digital Manufacturing Corp, Argon Medical Devices, and public healthcare firms such as Analogic Corp, AngioDynamics Inc, and Albany Molecular Research Inc (AMRI), where he still holds shares.( He began his career at General Electric, holding various finance positions for 14 years. Frost holds a BA in International Relations and Economics from Colgate University and is a graduate of the INSEAD Global Executive Program and GE Financial Management Program.(

Written by Perplexity from public sources.